Precision PromiseOkay, this is a big deal. There is tons of informaiton out there re this trial, but the most significant points I can find are these:
1. I believe the non-profit PanCAN will be funding and running this - ONC has been invited as an extedened arm of the trial and their cost will be supply only.
2. Only 175 patients necessary for registration approval.
3. We're still years away due to the OS endpoint but today's news is equivalent to a Big Pharma stepping up and partnerning with ONC for pancreatic cancer.
IMO, we're less than one month away from a complete buyout of ONC by some pharma.
Good news, congrats.
https://aacrjournals.org/cancerres/article/81/22_Supplement/PO-050/670425/Abstract-PO-050-Precision-Promise-PrP-An-adaptive